| Net Cash Provided by (Used in) Operating Activities |
$3,037,822 |
USD |
-1910% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$410,691 |
USD |
189% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$5,125,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
3,841,642 |
shares |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$7,752,035 |
USD |
-100302% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,099,076 |
USD |
7430% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$7,967,381 |
USD |
92% |
Q2 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Gross |
$8,055,960 |
USD |
94% |
Q2 2025 |
FY 2025 |
| Depreciation |
$592 |
USD |
-65% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$8,532,294 |
USD |
19% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$4,573,385 |
USD |
87% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$14,956,881 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$88,579 |
USD |
1789% |
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$33,409 |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
$63,861 |
USD |
2410% |
Q4 2024 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |